Changes in telepsychiatry regulations during the COVID-19 pandemic: 17 countries and regions' approaches to an evolving healthcare landscape
Open Access
- 27 November 2020
- journal article
- research article
- Published by Cambridge University Press (CUP) in Psychological Medicine
- Vol. 52 (13) , 2606-2613
Abstract
Background: During the COVID-19 pandemic, the use of telemedicine as a way to reduce COVID-19 infections was noted and consequently deregulated. However, the degree of telemedicine regulation varies from country to country, which may alter the widespread use of telemedicine. This study aimed to clarify the telepsychiatry regulations for each collaborating country/region before and during the COVID-19 pandemic.Methods: We used snowball sampling within a global network of international telepsychiatry experts. Thirty collaborators from 17 different countries/regions responded to a questionnaire on barriers to the use and implementation of telepsychiatric care, including policy factors such as regulations and reimbursement at the end of 2019 and as of May 2020.Results: Thirteen of 17 regions reported a relaxation of regulations due to the pandemic; consequently, all regions surveyed stated that telepsychiatry was now possible within their public healthcare systems. In some regions, restrictions on prescription medications allowed via telepsychiatry were eased, but in 11 of the 17 regions, there were still restrictions on prescribing medications via telepsychiatry. Lower insurance reimbursement amounts for telepsychiatry consultations v. in-person consultations were reevaluated in four regions, and consequently, in 15 regions telepsychiatry services were reimbursed at the same rate (or higher) than in-person consultations during the COVID-19 pandemic.Conclusions: Our results confirm that, due to COVID-19, the majority of countries surveyed are altering telemedicine regulations that had previously restricted the spread of telemedicine. These findings provide information that could guide future policy and regulatory decisions, which facilitate greater scale and spread of telepsychiatry globally.Keywords
This publication has 26 references indexed in Scilit:
- Telemedicine interventions for medication adherence in mental illness: A systematic reviewGeneral Hospital Psychiatry, 2020
- Improving Medication Adherence With Telemedicine for Adults With Severe Mental IllnessPsychiatric Services, 2019
- Treatment Compliance in the Long-Term Paranoid Schizophrenia Telemedicine StudyJournal of Technology in Behavioral Science, 2017
- Rapid Growth In Mental Health Telemedicine Use Among Rural Medicare Beneficiaries, Wide Variation Across StatesHealth Affairs, 2017
- Evaluating barriers to adopting telemedicine worldwide: A systematic reviewJournal of Telemedicine and Telecare, 2016
- Psychiatrist's adherence: a new factor in relapse prevention of schizophrenia. A randomized controlled study on relapse control through telemedicine systemJournal of Psychiatric and Mental Health Nursing, 2015
- A Survey and Review of Telemedicine License PortabilityTelemedicine and e-Health, 2015
- Telemedicine, Telehealth, and Mobile Health Applications That Work: Opportunities and BarriersThe American Journal of Medicine, 2014
- The Effectiveness of Telemental Health: A 2013 ReviewTelemedicine and e-Health, 2013
- Can Telepsychiatry Replace In-Person Psychiatric Assessments? A Review and Meta-Analysis of Comparison StudiesCNS Spectrums, 2005